Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 17:56:40 10/12/2024 GMT 		5-day change 1st Jan Change
773.11 USD -1.89% Intraday chart for Regeneron Pharmaceuticals, Inc. +2.66% -12.39%
12-09 Odronextamab Ash Presentations Underscore Impressive Potential in Early Lines of Treatment and Additional Types of Lymphoma CI
12-08 Regeneron Pharmaceuticals, Inc. Announces that Novel Combination of Pozelimab and Cemdisiran (Poze-Cemdi) Achieve Greater Control of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Compared to Ravulizumab CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 792.38 933.02 948.05
Spread/Res.-2.89%-17.52%-18.83%
Spread/Supp.+4.27%+4.27%+4.27%
Support 738.00 738.00 738.00

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. REGN Stock
  4. Charts Regeneron Pharmaceuticals, Inc.
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition